tiprankstipranks
The Ensign Group (DE:EGB)
XETRA:EGB
Germany Market

The Ensign Group (EGB) Blogger Opinions & Sentiment

2 Followers

Blogger Sentiment

Bullish: 80.00%
Sector Average
Bullish
DE:EGB Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
40% SeekingAlpha
40% Zacks
20% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Can Ensign Group's operating model drive growth beyond acquisitions
Zacks
Heres Why Ensign Group Stock Remains A Buy For Investors
Zacks
Ensign Group, Inc. (ENSG) -- Navigating Challenges in Healthcare | Wasatch Long Short Alpha Fund Q4 2025
GuruFocus
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of DE:EGB?
Seeking Alpha’s Number Cruncher has a Neutral Sentiment.
    What do Motley Fool contributors think of DE:EGB?
    Currently there's no blogger sentiment for DE:EGB.
    What Is DE:EGB’s Blogger Sentiment?
    DE:EGB’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for DE:EGB?
      The most recent blogger prediction for DE:EGB was made by Piyali Saha Sikdar, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          DFTXDefinium Therapeutics
          CNCCentene
          VERAVera Therapeutics
          SENSSenseonics Holdings